Capabilities by Region: United States

Greenhill has considerable advisory experience in the United States. Our Managing Directors and professionals have advised clients on transactions involving many of the leading companies in the region and have access to a vast network of corporate relationships throughout United States.

Greenhill established its presence in the United States in January 1996 with the opening of our office in New York. Greenhill further expanded its U.S. presence with the opening of Chicago and San Francisco offices in 2008 and the Houston office in 2009.

For more information on Greenhill’s advisory practice in the United States and our capabilities in the region, please contact Chief Executive Officer Scott Bok or President Kevin Costantino in our New York office.

Below we highlight a few of the transactions on which we have advised in this region:

Recent Transactions

23-Oct-14
$NA
Australia flag
Target: 

Boart Longyear Ltd.

flag not available

Advised the Board of Directors of Boart Longyear, the world’s leading supplier of drilling services and equipment for mining and drilling companies, on its strategic review process and subsequent comprehensive recapitalization transactions with certain affiliates of Centerbridge Partners, L.P.

30-Sep-14
$NA
United States flag
Target: 

Masco Corporation

flag not available

Advised Masco Corporation, a leading global provider of home improvement and building products, on the tax-free spin-off of its Installation Services business

09-Sep-14
$NA
United States flag
Target: 

Atwood Mobile Products, LLC

Sweden flag
Acquiror: 
Dometic Group AB

Advised Dometic Group AB, a portfolio company of EQT, on its acquisition of Atwood Mobile Products, a global manufacturer of appliances and hardware for the RV, On-/Off-Highway and Marine industries

03-Sep-14
$300 million
United States flag
Target: 

Voya Financial, Inc.

flag not available

Advised the Independent Committee of the Board of Directors of Voya Financial, Inc. in connection with Voya Financial, Inc.’s repurchase of 7.7mm shares (aggregate repurchase of $300mm) from ING Groep N.V.

11-Aug-14
$NA
United States flag
Target: 

MannKind Corporation

France flag
Acquiror: 
Sanofi

Advised MannKind, a biopharmaceutical company focused on the development of therapeutic products for patients with diabetes, on a collaboration with Sanofi, comprising licensing, supply and loan facility agreements with respect to licensing the Company’s lead product AFREZZA. MannKind will receive up to $925 million in upfront and milestone payments plus 35% of future profits.

Pages

show all